CMOPF
Price
$64.37
Change
+$9.37 (+17.04%)
Updated
May 28 closing price
Capitalization
827.91M
CSPCY
Price
$4.12
Change
+$0.18 (+4.57%)
Updated
Jul 3 closing price
Capitalization
9.91B
Interact to see
Advertisement

CMOPF vs CSPCY

Header iconCMOPF vs CSPCY Comparison
Open Charts CMOPF vs CSPCYBanner chart's image
Cosmo Pharmaceuticals
Price$64.37
Change+$9.37 (+17.04%)
Volume$200
Capitalization827.91M
CSPC Pharmaceuticals Group
Price$4.12
Change+$0.18 (+4.57%)
Volume$21.94K
Capitalization9.91B
CMOPF vs CSPCY Comparison Chart in %
Loading...
CMOPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CSPCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CMOPF vs. CSPCY commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMOPF is a Hold and CSPCY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (CMOPF: $64.37 vs. CSPCY: $4.12)
Brand notoriety: CMOPF and CSPCY are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: CMOPF: 100% vs. CSPCY: 786%
Market capitalization -- CMOPF: $827.91M vs. CSPCY: $9.91B
CMOPF [@Pharmaceuticals: Major] is valued at $827.91M. CSPCY’s [@Pharmaceuticals: Major] market capitalization is $9.91B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CMOPF’s FA Score shows that 1 FA rating(s) are green whileCSPCY’s FA Score has 2 green FA rating(s).

  • CMOPF’s FA Score: 1 green, 4 red.
  • CSPCY’s FA Score: 2 green, 3 red.
According to our system of comparison, CSPCY is a better buy in the long-term than CMOPF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CMOPF’s TA Score shows that 3 TA indicator(s) are bullish while CSPCY’s TA Score has 3 bullish TA indicator(s).

  • CMOPF’s TA Score: 3 bullish, 1 bearish.
  • CSPCY’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, CMOPF is a better buy in the short-term than CSPCY.

Price Growth

CMOPF (@Pharmaceuticals: Major) experienced а 0.00% price change this week, while CSPCY (@Pharmaceuticals: Major) price change was +2.50% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.13%. For the same industry, the average monthly price growth was +2.56%, and the average quarterly price growth was +9.33%.

Industries' Descriptions

@Pharmaceuticals: Major (+1.13% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CSPCY($9.91B) has a higher market cap than CMOPF($828M). CMOPF has higher P/E ratio than CSPCY: CMOPF (68.49) vs CSPCY (11.34). CSPCY YTD gains are higher at: 76.977 vs. CMOPF (-3.818). CSPCY has higher annual earnings (EBITDA): 7.63B vs. CMOPF (42.1M). CSPCY has higher revenues than CMOPF: CSPCY (31.1B) vs CMOPF (104M).
CMOPFCSPCYCMOPF / CSPCY
Capitalization828M9.91B8%
EBITDA42.1M7.63B1%
Gain YTD-3.81876.977-5%
P/E Ratio68.4911.34604%
Revenue104M31.1B0%
Total Cash222MN/A-
Total Debt176MN/A-
FUNDAMENTALS RATINGS
CMOPF vs CSPCY: Fundamental Ratings
CMOPF
CSPCY
OUTLOOK RATING
1..100
4873
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
21
Undervalued
PROFIT vs RISK RATING
1..100
10083
SMR RATING
1..100
5484
PRICE GROWTH RATING
1..100
6138
P/E GROWTH RATING
1..100
9713
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CMOPF's Valuation (15) in the null industry is in the same range as CSPCY (21). This means that CMOPF’s stock grew similarly to CSPCY’s over the last 12 months.

CSPCY's Profit vs Risk Rating (83) in the null industry is in the same range as CMOPF (100). This means that CSPCY’s stock grew similarly to CMOPF’s over the last 12 months.

CMOPF's SMR Rating (54) in the null industry is in the same range as CSPCY (84). This means that CMOPF’s stock grew similarly to CSPCY’s over the last 12 months.

CSPCY's Price Growth Rating (38) in the null industry is in the same range as CMOPF (61). This means that CSPCY’s stock grew similarly to CMOPF’s over the last 12 months.

CSPCY's P/E Growth Rating (13) in the null industry is significantly better than the same rating for CMOPF (97). This means that CSPCY’s stock grew significantly faster than CMOPF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CMOPFCSPCY
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
20%
Bullish Trend 2 days ago
65%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
78%
MACD
ODDS (%)
Bearish Trend 2 days ago
6%
Bearish Trend 2 days ago
63%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
23%
Bullish Trend 2 days ago
68%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
23%
Bullish Trend 2 days ago
67%
Advances
ODDS (%)
N/A
Bullish Trend 2 days ago
68%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
74%
Aroon
ODDS (%)
Bullish Trend 2 days ago
23%
Bullish Trend 2 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
CMOPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CSPCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TDIV92.320.70
+0.76%
First Trust NASDAQ Technology Div ETF
GYLD13.230.06
+0.48%
Arrow Dow Jones Global Yield ETF
FSMB19.930.02
+0.10%
First Trust Short Dur Mgd Muncpl ETF
RAAX31.80-0.02
-0.06%
VanEck Real Assets ETF
LDRT25.11-0.03
-0.14%
iShares iBonds 1-5 Year Treasury Ladder ETF

CMOPF and

Correlation & Price change

A.I.dvisor tells us that CMOPF and GSK have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CMOPF and GSK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMOPF
1D Price
Change %
CMOPF100%
N/A
GSK - CMOPF
22%
Poorly correlated
-0.86%
NVS - CMOPF
21%
Poorly correlated
-1.54%
CHGCY - CMOPF
7%
Poorly correlated
-0.89%
DSNKY - CMOPF
5%
Poorly correlated
-2.41%
CSPCY - CMOPF
4%
Poorly correlated
+4.50%
More

CSPCY and

Correlation & Price change

A.I.dvisor tells us that CSPCY and CHJTF have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CSPCY and CHJTF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSPCY
1D Price
Change %
CSPCY100%
+4.50%
CHJTF - CSPCY
23%
Poorly correlated
N/A
DSNKY - CSPCY
16%
Poorly correlated
-2.41%
BAYZF - CSPCY
12%
Poorly correlated
-0.90%
DSKYF - CSPCY
5%
Poorly correlated
-2.39%
CMOPF - CSPCY
4%
Poorly correlated
N/A
More